Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 13, No 1 (2017) MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE Abstract  similar documents
N. F. Puchinian, N. V. Furman, L. I. Malinova, P. V. Dolotovskaya
"... to obtain the necessary information on the issue of control of antiplatelet therapy. The review brings ..."
 
Vol 9, No 6 (2013) ANTIPLATELET THERAPY CONTROL: CREDIBILITY GAP OR SEARCH FOR NEW DECISIONS? Abstract  similar documents
Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein
"... heart disease after percutaneous coronary intervention and its contribution to antiplatelet therapy ..."
 
Vol 10, No 5 (2014) DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE Abstract  similar documents
G. N. Guseva, T. V. Pavlova, I. L. Voronova, S. M. Chohlunov
"... Aim. To evaluate an adequacy of dual antiplatelet therapy (DAPT) in patients with acute coronary ..."
 
Vol 7, No 1 (2011) THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS Abstract  similar documents
O. V. Gaisenok
"... Current issues of atherothrombosis prevention and treatment optimization with antiplatelet therapy ..."
 
Vol 3, No 3 (2007) RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
D. H. Aynetdinova, A. E. Udovichenko, V. A. Sulimov
"... to antiplatelet drugs. There are many methods to detect sensitivity to antiplatelet drugs, but they all have ..."
 
Vol 6, No 2 (2010) THE MODERN ASPECTS OF CLOPIDOGREL USE Abstract  similar documents
E. N. Dankovtseva, D. A. Zateyshchikov
"... оригинального и дженерического препаратов клопидогрела. Ключевые слова: клопидогрел, антитромбоцитарная терапия ..."
 
Vol 7, No 4 (2011) ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID Abstract  similar documents
I. N. Bokarev, L. V. Popova
"... is highlighted. ASA modes of action and its position among the modern antiplatelet agents are considered ..."
 
Vol 9, No 6 (2013) THE ROLE OF P-GLYCOPROTEIN IN RATIONAL PHARMACOTHERAPY IN CARDIOLOGY Abstract  similar documents
A. V. Shulkin, E. N. Yakusheva, N. M. Popova
"... , in rational pharmacotherapy in cardiology was shown on the example of its substrates – digoxin, antiplatelet ..."
 
Vol 13, No 4 (2017) PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW Abstract  similar documents
I. S. Yavelov
"... Prerequisites for the prolonged dual antiplatelet therapy after myocardial infarction are presented ..."
 
Vol 10, No 6 (2014) THE SIGNIFICANCE OF PLATELET FUNCTIONAL ACTIVITY TESTING IN THE PREVENTION OF CARDIOVASCULAR COMPLICATIONS IN PATIENTS RECEIVING ANTIPLATELET THERAPY Abstract  similar documents
D. A. Andreev
"... complications in patients receiving antiplatelet therapy is presented. Indications for antiplatelet therapy ..."
 
Vol 6, No 5 (2010) METHODICAL APPROACHES TO THE ANALYSIS OF THE RESULTS OF RESEARCH ACTIVITIES Abstract  similar documents
S. A. Trushchelev, R. G. Oganov
"... The value of scientific medical information and its impact indicators (researcher’s publishing ..."
 
Vol 4, No 2 (2008) ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION Abstract  similar documents
D. H. Ainetdinova, A. Е. Udovichenko, V. A. Sulimov
"... of antiplatelet therapy resistance is significantly higher in patients with diabetes mellitus and obesity (р<0 ..."
 
Vol 7, No 1 (2011) NEW ANTIPLATELET DRUGS (PART 1) Abstract  similar documents
A. B. Sumarokov
"... Antiplatelet agents are a necessary component of modern atherosclerosis therapy. The difficulties ..."
 
Vol 7, No 4 (2011) VASCULAR BED PECULIAR PROPERTIES IN PATIENTS WITH ISCHEMIC HEART DISEASE AND ARTERIAL HYPERTENSION. ROLE OF ANTIPLATELET THERAPY Abstract  similar documents
L. A. Haisheva, S. V. Shlyk
"... of revealed disorders with antiplatelet agent — clopidogrel 75 mg/day. Material and methods. 40 patients ..."
 
Vol 8, No 1 (2012) RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION Abstract  similar documents
V. A. Sulimov, E. V. Moroz
"... of cardiovascular complications and activity of platelet aggregation, to assess safety of dual antiplatelet therapy ..."
 
Vol 6, No 1 (2010) ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS Abstract  similar documents
M. Yu. Gilyarov, V. A. Sulimov
"... The problem of antiplatelet drug choice in patients with atrial fibrillation is discussed. Authors ..."
 
Vol 9, No 4 (2013) COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE Abstract  similar documents
L. E. Kuvshinova, N. V. Furman, P. V. Dolotovskaya, Ya. P. Dovgalevsky
"... на контроль международного нормализованного отношения (МНО) в условиях поликлиники; затраты на визиты ..."
 
Vol 6, No 2 (2010) EFFICACY AND SAFETY OF ACIDUM ACETYLSALICYLICUM USAGE Abstract  similar documents
V. N. Drozdov, V. A. Kim
"... Data about efficacy and safety of acetylsalicylic acid usage as antiplatelet drug and for cancer ..."
 
Vol 10, No 3 (2014) THE CAPABILITIES OF A REGISTER AS A QUALITY CONTROL OF THE PHARMACOTHERAPY IN OUTPATIENTS AT HIGH RISK OF CARDIOVASCULAR COMPLICATIONS (THE "LIS-1" REGISTER) Abstract  similar documents
M. L. Ginzburg, S. Y. Martsevich, N. P. Kutishenko, Y. V. Lukina, A. D. Deev
"... receiving b-blockers, 35.3% - renin-angiotensin-aldosterone system (RAAS) inhibitors, 15.7% - antiplatelet ..."
 
Vol 10, No 4 (2014) OPTIMAL PREVENTION OF HOSPITAL VENOUS THROMBOEMBOLISM WITH THE HELP OF MEDICAL INFORMATION SYSTEM Abstract  similar documents
G. I. Nazarenko, S. A. Payushk, V. A. Otdelenov, E. B. Kleymenova, L. P. Yashina, D. A. Sychev
"... with other health information systems and care flow processes. ..."
 
Vol 10, No 4 (2014) FEATURES OF THE CARDIOVERSION IN ATRIAL FLUTTER AND FIBRILLATION IN ERA OF NEW ANTICOAGULANTS: PRACTICAL CARDIOLOGIST VIEW Abstract  similar documents
S. A. Zenin, A. V. Fedoseenko, O. V. Kononenko, O. V. Pyataeva
"... Разбирают стратегии ведения пациентов с фибрилляцией предсердий (ФП): контроль ритма сердца или ..."
 
Vol 2, No 3 (2006) ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? Abstract  similar documents
I. A. Latfullin, A. A. Podolskaya
"... of action and clinical efficiency of antithrombotic and antiplatelet medicines such as acetylsalicylic acid ..."
 
Vol 7, No 5 (2011) ANTITHROMBOTIC THERAPY IN ATRIAL FIBRILLATION: RECENT APPROACHES AND NEAR PERSPECTIVES Abstract  similar documents
Ya. P. Dovgalevskiy, L. E. Kuvshinova, I. V. Graifer, N. V. Furman, P. Ya. Dovgalevskiy
"... therapy , last information about their efficacy , safety and potential of application. ..."
 
Vol 8, No 2 (2012) UP TO DATE ANTIPLATELET THERAPY IN PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS AND REAL CLINICAL PRACTICE Abstract  similar documents
S. Yu. Martsevich, V. P. Voronina, M. L. Ginzburg, N. P. Kutishenko, Yu. N. Polyanskaya, T. G. Kheliya, A. M. Malysheva, S. N. Tolpygina, V. S. Kutuzova, E. A. Gofman, A. D. Deev
"... Aim. To assess the real rate of dual antiplatelet therapy (DAT, acetylsalicylic acid + clopidogrel ..."
 
Vol 7, No 5 (2011) NEW ANTIPLATELET DRUGS. PART 2 Abstract  similar documents
A. B. Sumarokov
"... Antiplatelet agents are a necessary component of modern therapy of atherosclerosis ..."
 
Vol 12, No 4 (2016) High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice Abstract  similar documents
N. F. Puchinyan, N. V. Furman, P. V. Dolotovskaya, L. L. Malinova
"... antiplatelet therapy (DAT) with acetylsalicylic acid (ASA) and clopidogrel by optical aggregometry in patients ..."
 
Vol 11, No 4 (2015) EVALUATION OF COST-EFFECTIVENESS OF PLATELET REACTIVITY ANALYSIS USING THE VERIFYNOW P2Y12 ASSAY IN PATIENTS AFTER ACUTE CORONARY SYNDROME Abstract  similar documents
A. V. Rudakova, N. V. Lomakin
"... Dual antiplatelet therapy, including clopidogrel and aspirin, in a significant share of patients ..."
 
Vol 8, No 4 (2012) ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE Abstract  similar documents
S. R. Gilyarevskiy, V. A. Orlov, I. M. Kuz'mina, A. G. Larin
"... Alternative approaches to the use of two component antiplatelet therapy in patients with acute ..."
 
Vol 14, No 2 (2018) FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova
"... in patients with stable angina significantly increased: antiplatelets – up to 82.7%, beta-blockers – up to 74 ..."
 
Vol 14, No 2 (2018) New Possibilities of Antithrombotic Therapy of Patients with Peripheral and Widespread Atherosclerotic Lesion Abstract  similar documents
A. L. Komarov, Е. S. Novikova, E. V. Guskova, Е. B. Yarovaya, A. N. Samko, E. Р. Panchenko
"... efficiency of present antiplatelet and anticoagulant drugs is shown in the key of preventing PAD thrombotic ..."
 
Vol 4, No 1 (2008) COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE Abstract  similar documents
N. A. Belolipetskiy, S. N. Tolpygina, O. А. Litinskaya, V. G. Belolipetskaya, S. Yu. Martsevich
"... Aim. To compare antiplatelet effect of two acetylsalicylic acid medicines, Acecardol ("Synthesis ..."
 
Vol 3, No 4 (2007) RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA Abstract  similar documents
N. F. Putchinyan, N. V. Furman, P. Ya. Dovgalevskyi
"... , antiplatelet therapy, resistance, platelet functional activity. Rational Pharmacother. Card. 2007;4:11-14 ..."
 
Vol 5, No 5 (2009) EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME Abstract  similar documents
A. L. Alyavi, R. A. Rakhimov, B. A. Alyavi
"... and combined antiplatelet therapy (acetylsalicylic acid and clopidogrel). Material and methods. 98 patients ..."
 
Vol 6, No 4 (2010) ACC/AHA CLOPIDOGREL CLINICAL ALERT. WHAT MUST BE MODERN ANTIPLATELET THERAPY? Abstract  similar documents
S. J. Martsevich
"... antiplatelet therapy? S.J. Martsevich* State Research Center for Preventive Medicine. Petroverigsky per. 10 ..."
 
Vol 13, No 2 (2017) SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova
"... recommended for patients with a history of myocardial infarction (antiplatelets – 91.76%, beta-blockers – 83 ..."
 
Vol 6, No 6 (2010) COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR) Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, E. S. Boychenko, R. E. Dubinskaya, Yu. V. Lukina, V. P. Voronina
"... Aim. To compare the antiplatelet efficacy of the original and generic enterosoluble tableted ..."
 
Vol 10, No 5 (2014) DIABETIC CARDIOMYOPATHY. RESISTIN: A CONTROL OF A MYOCARDIAL HYPERTROPHY Abstract  similar documents
An. A. Aleksandrov, O. A. Shatskaya, S. S. Kuharenko, M. N. Yadrihinskaya, E. N. Abdalkina, E. N. Drozdova, M. V. Shestakova
"... включено 60 больных (12 мужчин и 48 женщин) СД 2 типа с ишемической болезнью серд- Сведения об авторах ..."
 
Vol 6, No 5 (2010) LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS? Abstract  similar documents
I. V. Zhirov
"... Представлены сведения, касающиеся эффективности и безопасности длительной терапии ..."
 
Vol 7, No 6 (2011) ANTI-INFLAMMATORY EFFECT OF CLOPIDOGREL IN ATHEROSCLEROSIS Abstract  similar documents
L. I. Buriachkovskaia, A. B. Sumarokov, I. A. Uchitel, E. M. Gupalo
"... - го рецептора к АДФ. Этот рецептор наиболее привле- Сведения об авторах: Бурячковская Людмила ..."
 
Vol 5, No 3 (2009) ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2 Abstract  similar documents
E. V. Gorjacheva, A. E. Udovichenko, V. A. Sulimov, N. V. Lavrishcheva, M. A. Surikova, T. N. Gracheva
"... ,007 in G2). Conclusion. Resistance to antiplatelet drugs is observed more often in patients with DM2 ..."
 
Vol 9, No 3 (2013) RENAL DENERVATION IN RESISTANT ARTERIAL HYPERTENSION Abstract  similar documents
V. A. Sulimov, A. V. Rodionov, A. A. Svetankova, I. E. Deneka
"... . General information about resistant hypertension, method of renal denervation, the results of clinical ..."
 
Vol 11, No 1 (2015) XI RUSSIAN RESEARCH/PRACTICE CONFERENCE OF RSCRSP (ROSOKR) WITH INTERNATIONAL PARTICIPATION “REHABILITATION AND SECONDARY PREVENTION IN CARDIOLOGY” 23-24 APRIL 2015, MOSCOW Abstract  similar documents
"... Information letter. ..."
 
Vol 11, No 2 (2015) CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE Abstract  similar documents
K. A. Kireev, A. V. Krasnopeev, T. S. Kireeva
"... antiplatelet drugs (acetylsalicylic acid and clopidogrel) and heparin. There were not any reasons ..."
 
Vol 5, No 1 (2009) INFORMATION LETTER ABOUT NATIONAL CONGRESS OF CARDIOLOGY, 6-8 OCTOBER, 2009 Abstract  similar documents
"... Information letter about National Congress of Cardiology, 6-8 October, 2009. ..."
 
Vol 11, No 1 (2015) ALL-RUSSIA RESEARCH/PRACTICE CONFERENCE “NON-INFECTIOUS DISEASES AND PUBLIC HEALTH IN RUSSIA” 28-29 MAY 2015, MOSCOW Abstract  similar documents
"... Information letter. ..."
 
Vol 11, No 3 (2015) RUSSIAN NATIONAL CONGRESS OF CARDIOLOGY, 22-25 SEPTEMBER 2015, MOSCOW Abstract  similar documents
"... Information letter. ..."
 
Vol 11, No 2 (2015) RUSSIAN NATIONAL CONGRESS OF CARDIOLOGY, 22-25 SEPTEMBER 2015, MOSCOW Abstract  similar documents
"... Information letter. ..."
 
Vol 11, No 1 (2015) EVALUATION OF PLATELET AGGREGATION IN CLINICAL PRACTICE Abstract  similar documents
K. B. Mirzaev, D. A. Andreev, D. A. Sychev
"... Evaluation of platelet function with subsequent modification of antiplatelet therapy regimen ..."
 
Vol 11, No 4 (2015) INFLUENCE OF THE CYP3A4 ISOENZYME METABOLIC ACTIVITY AND CYP2C19 GENE POLYMORPHISMS ON CLOPIDOGREL ANTIPLATELET EFFECT IN PATIENTS WITH ACUTE CORONARY SYNDROME UNDERGOING PERCUTANEOUS CORONARY INTERVENTION Abstract  PDF (Eng)  similar documents
K. B. Mirzaev, R. E. Kazakov, V. V. Smirnov, D. A. Andreev, D. A. Sychev
"... of clopidogrel’s active metabolite and, respectively, its antiplatelet effect. We sought to determine the impact ..."
 
Vol 11, No 5 (2015) Three-year dynamics and unsolved problems of lipid-lowering therapy Abstract  similar documents
V. A. Sergeeva
"... Цель. Изучить проводимую гиполипидемическую терапию, адекватность ее контроля, а также ..."
 
Vol 9, No 4 (2013) THE SIGNIFICANCE OF PHARMACOGENETIC CYP2C19 TESTING FOR PERSONALIZATION OF THE ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE Abstract  similar documents
K. B. Mirzaev, D. A. Sychev, D. A. Andreev, A. B. Prokofiev
"... is discussed. Approaches to antiplatelet agent choice according to pharmacogenetic CYP2C19 testing, as well ..."
 
Vol 9, No 1 (2013) POSSIBILITIES OF CLINICAL LABORATORY EVALUATION OF ANTIPLATELET THERAPY EFFECTIVENESS IN PATIENTS WITH ISCHEMIC HEART DISEASE Abstract  similar documents
O. V. Sirotkina, A. B. Laskovets, A. S. Lipunova, L. B. Gaykovaya, S. A. Boldueva, T. V. Vavilova
"... and induced flow cytofluorometry during antiplatelet therapy with clopidogrel and acetylsalicylic acid (ASA ..."
 
Vol 5, No 1 (2009) UP TO DATE INFORMATION FOR LEADING CARDIOLOGISTS AND THERAPEUTISTS ABOUT LATEST PREVENTION AND THERAPY METHODS REDUCES GROWTH RATE OF CARDIOVASCULAR DISEASES Abstract  similar documents
E. Aleeva
"... Up to date information for leading cardiologists and therapeutists about latest prevention ..."
 
Vol 10, No 1 (2014) HOW TO INCREASE ACCESSIBILITY OF BIOMEDICAL INFORMATION? EDITORS’ NETWORK INITIATIVE OF THE NATIONAL SOCIETY CARDIOVASCULAR JOURNALS OF THE EUROPEAN SOCIETY OF CARDIOLOGY Abstract  similar documents
I. P. Kolos, D. A. Anichkov, R. G. Oganov
"... , ул. Островитянова, 1 Сведения об авторах: Колос Игорь Петрович – к.м.н., с.н.с. отдела клинической ..."
 
Vol 7, No 5 (2011) HIGH VERSUS STANDARD CLOPIDOGREL MAINTENANCE DOSE AFTER PERCUTANEOUS CORONARY INTERVENTION AND EFFECTS ON PLATELET INHIBITION, ENDOTHELIAL FUNCTION, AND INFLAMMATION. RESULTS OF THE ARMYDA-150 MG (ANTIPLATELET THERAPY FOR REDUCTION OF MYOCARDIAL DAMAGE DURING ANGIOPLASTY) RANDOMIZED STUDY  similar documents
G. Patti, D. Grieco, G. Dicuonzo, V. Pasceri, A. Nusca, G. Sciascio
"... статьи осуществлены с разрешения American College of Cardiology под контролем экспертов ВНОК. Статья G ..."
 
Vol 14, No 5 (2018) Drug Therapy Structure and Clinical Characteristics of Patients with Atrial Fibrillation According to Data of REKUR-AF Study Abstract  similar documents
I. L. Polshakova, S. V. Povetkin
"... , laboratory and instrumental examination data, information about hospitalizations for the last year ..."
 
Vol 7, No 3 (2011) MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE Abstract  similar documents
S. Yu. Martsevich, M. L. Ginzburg, A. M. Malysheva, Yu. N. Polyanskaya, T. G. Kheliya, N. P. Kutishenko
"... the need of dual antiplatelet agents therapy. ..."
 
Vol 11, No 1 (2015) PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION Abstract  similar documents
A. V. Rudakova
"... (warfarin), antiplatelet therapy (acetylsalicylic acid) and novel oral anticoagulants such as apixaban ..."
 
Vol 13, No 4 (2017) CLINICAL ADVANTAGES OF TELMISARTAN: FEATURES OF PHARMACOKINETICS, PHARMACODYNAMICS AND EFFECTS ON THE DAILY BLOOD PRESSURE PROFILE Abstract  similar documents
O. D. Ostroumova, E. A. Smolyarchuk, O. V. Bondarec, E. E. Paleeva
"... важно для контроля артериального давления (АД) в ранние утренние часы. Представлены данные исследований ..."
 
Vol 9, No 6 (2013) DYNAMICS IN MEDICAL TREATMENT OF ISCHEMIC HEART DISEASE IN CLINICAL PRACTICE Abstract  PDF (Eng)  similar documents
S. A. Shalnova, A. D. Deev, S. A. Boytsov
"... increased by 13% in the both genders. Men with IHD received antiplatelet agents more often than women. So ..."
 
Vol 5, No 5 (2009) ADVANTAGES OF FIX COMBINATION THERAPY FOR REACHING BLOOD PRESSURE TARGET LEVELS IN PATIENTS WITH ARTERIAL HYPERTENSION (RESULTS OF CLIP-ACCORD PROGRAM) Abstract  similar documents
I. E. Chazova, S. A. Boicov, Yu. A. Karpov, L. G. Ratova, G. P. Artyunov, A. S. Galyavich, R. S. Karpov, O. M. Kislyak, A. I. Martynow, I. V. Medvedeva, V. B. Mychka, O. D. Ostroumova, G. I. Simonova, T. V. Tyurina, S. A. Shalnova, S. S. Yakushin
"... Information letter of Russian Medical Society of Arterial Hypertension. ..."
 
Vol 13, No 6 (2017) ATRIAL FIBRILLATION AND CHRONIC HEART FAILURE: PRACTICAL ASPECTS AND DISCUSSION ISSUES OF RATIONAL PHARMACOTHERAPY Abstract  similar documents
Yu. А. Bunin, S. V. Miklishanskaya
"... удержания синусового ритма не имеет преимуществ перед контролем частоты желудочковых сокращений. В обзоре ..."
 
Vol 12, No 6 (2016) EFFICIENCY OF INFLUENZA VACCINATION IN PATIENTS WITH CIRCULATORY SYSTEM DISEASES UNDER DISPENSARY OBSERVATION IN OUTPATIENT CLINICS: PROSPECTIVE FOLLOW-UP MONITORING DATA Abstract  similar documents
S. A. Boytsov, M. M. Loukianov, E. V. Platonova, V. M. Gorbunov, S. V. Romanchuk, O. A. Nazarova, O. A. Belova, E. A. Kravtsova, P. Ya. Dovgalevsky, N. V. Furman, A. A. Mironova, P. V. Dolotovskaya, A. V. Nekrasov, N. G. Puchkova, M. A. Abramova, E. N. Belova, V. G. Klyashtorny, A. D. Deev
"... . Саратова по данным трехлетнего проспективного контроля. Включено в исследование 817 человек, из них ..."
 
Vol 12, No 2 (2016) ATRIAL FIBRILLATION AND ISCHEMIC HEART DISEASE: HOW TO COMBINE ANTIPLATELET AND ANTICOAGULANT THERAPY, DEPENDING ON THE CLINICAL SITUATION? Abstract  similar documents
D. A. Napalkov, A. A. Sokolova, A. V. Rodionov
"... antiplatelet and anticoagulant therapy, depending on the clinical situation? D.A. Napalkov*, A.A. Sokolova, A ..."
 
Vol 9, No 5 (2013) TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER (PART 2) Abstract  similar documents
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich
"... лекарственной тера- пии, ее соответствие современным КР у больных ХИБС остается актуальной задачей. Сведения об ..."
 
Vol 10, No 2 (2014) ANALYSIS OF ANTITHROMBOTIC THERAPY IN IN-PATIENTS WITH PERMANENT ATRIAL FIBRILLATION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
V. I. Petrov, O. V. Shatalova, A. S. Maslakov
"... .7%). Antiplatelet drugs were used in 25.4% of cases, including for patients with high risk of thromboembolic ..."
 
Vol 10, No 3 (2014) COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION Abstract  similar documents
A. V. Rudakova, V. A. Parfenov
"... K antagonists (such as warfarin), antiplatelet therapy (such as acetylsalicylic acid) and novel oral ..."
 
Vol 1, No 1 (2005) ACE INHIBITORS IN PATIENTS WITH ISCHEMIC HEART DISEASE WITHOUT HEART FAILURE: CLASS EFFECTS AND EFFICACY OF ITS REPRESENTATIVES Abstract  similar documents
Y. A. Karpov
"... to antiplatelet, lipid reducing remedies and beta-blockers. ..."
 
Vol 7, No 6 (2011) NEW ANTIARRHYTHMIC DRUG FOR THE TREATMENT OF ATRIAL FIBRILLATION. STUDY DATA, CLINICAL GUIDELINES, REGULATORY AGENCY RECOMMENDATIONS Abstract  similar documents
S. Yu. Martsevich, Yu. V. Lukina
"... information about its safety. ..."
 
Vol 10, No 6 (2014) PHARMACOGENETIC TESTING OPPORTUNITIES IN CARDIOLOGY BASED ON EXOME SEQUENCING Abstract  similar documents
N. V. Shcherbakova, A. I. Ershova, A. A. Suvorova, E. Y. Hlebus, A. N. Meshkov, S. A. Boytsov
"... Aim. To study what cardiac drugs currently have any comments on biomarkers and what information ..."
 
Vol 12, No 5 (2016) Clinical and Laboratory Predictors of Major Adverse Cardiac Events in Patients with Ischemic Heart Disease Following Elective Percutaneous Coronary Intervention Abstract  similar documents
E. Z. Golukhova, M. V. Grigoryan, M. N. Ryabinina, N. I. Bulaeva
"... antiplatelet therapy with acetyl salicylic acid and clopidogrel. Numerous clinical characteristics ..."
 
Vol 11, No 1 (2015) III INTERNATIONAL CONGRESS “ARTERIAL HYPERTENSION – FROM KOROTKOV TO THIS DATE” 21-23 MAY 2015, ST. PETERSBURG Abstract  similar documents
"... Information letter. ..."
 
Vol 11, No 3 (2015) V CAUCASUS SCIENTIFIC AND EDUCATIONAL CONFERENCE OF CARDIOLOGY AND INTERNAL MEDICINE, 27-28 OCTOBER, 2015, NALCHIK Abstract  similar documents
"... Information letter. ..."
 
Vol 11, No 3 (2015) 4TH ALL-RUSSIA CONFERENCE “CONTRADICTIONS OF THE MODERN CARDIOLOGY: CONTROVERSIAL AND OPEN QUESTIONS” AND 3RD FORUM OF THE YOUNG CARDIOLOGISTS, 16-17 NOVEMBER 2015, SAMARA Abstract  similar documents
"... Information letter. ..."
 
Vol 11, No 2 (2015) III INTERNATIONAL CONGRESS “ARTERIAL HYPERTENSION – FROM KOROTKOV TO THIS DATE” 21-23 MAY 2015, ST. PETERSBURG Abstract  similar documents
"... Information letter. ..."
 
Vol 11, No 2 (2015) 4TH ALL-RUSSIA CONFERENCE “CONTRADICTIONS OF THE MODERN CARDIOLOGY: CONTROVERSIAL AND OPEN QUESTIONS” AND 3RD FORUM OF THE YOUNG CARDIOLOGISTS, 16-17 NOVEMBER 2015, SAMARA Abstract  similar documents
"... Information letter. ..."
 
Vol 11, No 4 (2015) V CAUCASUS SCIENTIFIC AND EDUCATIONAL CONFERENCE OF CARDIOLOGY AND INTERNAL MEDICINE, 27-28 OCTOBER, 2015, NALCHIK Abstract  similar documents
"... Information letter. ..."
 
Vol 11, No 4 (2015) RUSSIAN NATIONAL CONGRESS OF CARDIOLOGY, 22-25 SEPTEMBER 2015, MOSCOW Abstract  similar documents
"... Information letter. ..."
 
Vol 11, No 4 (2015) 4TH ALL-RUSSIA CONFERENCE “CONTRADICTIONS OF THE MODERN CARDIOLOGY: CONTROVERSIAL AND OPEN QUESTIONS” AND 3RD FORUM OF THE YOUNG CARDIOLOGISTS, 16-17 NOVEMBER 2015, SAMARA Abstract  similar documents
"... Information letter. ..."
 
Vol 10, No 4 (2014) IV CAUCASUS SCIENTIFIC AND EDUCATIONAL CONFERENCE OF CARDIOLOGY AND INTERNAL MEDICINE, OCTOBER 28-29, 2014 Abstract  similar documents
"... Information letter. ..."
 
Vol 10, No 5 (2014) IV INTERNATIONAL FORUM OF CARDIOLOGISTS AND INTERNAL MEDICINE SPECIALISTS, MARCH 26-28, 2015, MOSCOW Abstract  similar documents
"... Information letter. ..."
 
Vol 10, No 3 (2014) IV CAUCASUS SCIENTIFIC AND EDUCATIONAL CONFERENCE OF CARDIOLOGY AND INTERNAL MEDICINE, OCTOBER 28-29, 2014 Abstract  similar documents
"... Information letter. ..."
 
Vol 14, No 6 (2018) Specific Antidotes for Direct Oral Anticoagulants in Life-Threatening Bleeding Abstract  PDF (Eng)  similar documents
A. B. Sumarokov, L. I. Buryachkovskaya, N. V. Lomakin
"... taking new oral anticoagulants. Information concerning use of antidotes for DOACs in bleedings as well ..."
 
Vol 9, No 2 (2013) ELECTROCARDIOGRAM ST SEGMENT DEPRESSION AND ELEVATION IN STRESS-TESTING Abstract  similar documents
D. A. Kuzhel, G. V. Matyushin, T. D. Fedorova, N. V. Kovaleva, E. A. Savchenko, S. E. Golovenkin
"... . Important information for patient management and prognosis determination can be derived from the stress ..."
 
Vol 8, No 2 (2012) EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES Abstract  similar documents
S. N. Tolpygina, S. Yu. Martsevich, E. N. Khoseva, N. V. Kiseleva
"... , as well as ways to improve the safety of antiplatelet therapy are presented, including use of enteric ..."
 
Vol 6, No 5 (2010) THE CONGRESS OF THE EUROPEAN SOCIETY OF CARDIOLOGY 2010 IN STOCKHOLM: NEWS FOR PRACTITIONERS Abstract  similar documents
S. Yu. Martsevich
"... significant events of the Congress are discussed. Symposia on antiplatelet therapy, hypertension, and recently ..."
 
Vol 13, No 5 (2017) DRUG INTERACTIONS OF NEW ORAL ANTICOAGULANTS: INSIDE AND OUTSIDE TABLE CELLS Abstract  similar documents
S. N. Bel'diev, I. V. Medvedeva, D. Yu. Platonov
"... inconsistent with primary source  of information of NOAC drug interactions, and provides the updated ..."
 
Vol 4, No 5 (2008) EVALUATION OF QUALITY OF ARTERIAL HYPERTENSION CONTROL IN POPULATION OF VOLOGDA REGION Abstract  similar documents
A. I. Popugaev, G. Т Banshikov, A. A. Kolinko, N. A. Korolenko, R. A. Kasimov, Д. А. Rybakov, А. М. Kalinina
"... Цель. Изучить опыт внедрения и результаты технологии регистрации, учета и оценки качества контроля ..."
 
Vol 13, No 5 (2017) RATIONAL PHARMACOTHERAPY IN CARDIOLOGY: FROM ROUTINE CONTROL TO EFFECTIVE MANAGEMENT Abstract  similar documents
N. А. Nikolayev, Y. P. Skirdenko, S. S. Bunova, A. V. Ershov
 
Vol 13, No 1 (2017) ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY Abstract  similar documents
E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko
"... as first-line drugs for stroke prevention, but in real medical practice antiplatelet drugs are often ..."
 
Vol 12, No 5 (2016) II Interregional Conference of Cardiologists and Internists, Ulyanovsk, 5-6 December 2016 Information letter Abstract  similar documents
Editorial article
 
Vol 12, No 4 (2016) VI Caucasus scientific and educational conference of cardiology and internal medicine, 25-26 October, 2016. Information letter Abstract  similar documents
Article Editorial
"... ) / Рациональная Фармакотерапия в Кардиологии 2016;12(4) Information Информация Правила оформления тезисов: 1 ..."
 
Vol 14, No 6 (2018) VIII International Forum of Cardiology and Internal Medicine, 27-29 March 2019, Moscow. Information letter Abstract  PDF (Eng)  similar documents
artilce Editorial
 
Vol 4, No 3 (2008) ANTITHROMBOTIC THERAPY AT PERCUTANEOUS CORONARY INTERVENTIONS Abstract  similar documents
V. A. Sulimov
"... Possibilities of modern antiplatelet and antithrombotic therapy at percutaneous coronary ..."
 
Vol 12, No 3 (2016) ADVERSE EVENT OF DRUG THERAPY (THE FIRST RESULTS OF THE STUDY ACCORDING TO THE PROFILE OUTPATIENT REGISTER) Abstract  PDF (Eng)  similar documents
Yu. V. Lukina, N. A. Dmitrieva, A. V. Zakharova, A. V. Zagrebelnyy, N. P. Kutishenko, S. Yu. Martsevich
"... due to the growth of the pharmaceutical market. Incomplete information about AEs of drug therapy ..."
 
Vol 4, No 2 (2008) BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL Abstract  similar documents
A. N. Zakirova, F. S. Zarudij, B. N. Garifullin
"... . The current view on of beta-blocker antiplatelet effects is presented on the basis of physical and chemical ..."
 
Vol 9, No 6 (2013) PHARMACOTHERAPY AND OUTCOMES OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION – GENDER DIFFERENCES IN REAL CLINICAL PRACTICE Abstract  similar documents
P. V. Dolotovskaya, E. Y. Rudnichenko, N. V. Furman, O. V. Reshet'ko
"... (84% vs 91%; p<0.05) and dual antiplatelet therapy (21% vs 59%; p<0.05). Hospital mortality ..."
 
Vol 9, No 2 (2013) ANTITHROMBOTIC THERAPY SAFETY MONITORING BASED ON SPONTANEOUS REPORTS Abstract  similar documents
O. V. Shatalova, O. N. Smuseva, A. S. Maslakov
"... .2% (4/18), and antiplatelet drugs 11.1% (2/18). Conclusion. Warfarin was more often cause of ADR during ..."
 
Vol 9, No 5 (2013) PRIMARY CARE PROBLEMS IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
O. A. Shtegman
"... . An anonymous survey among doctors in terms of current CHF guidelines knowledge, patient information provided ..."
 
Vol 6, No 4 (2010) CLOPIDOGREL PHARMACOGENETICS Abstract  similar documents
A. N. Meshkov
"... in atherosclerosis progression and thrombotic complications. That is why antiplatelet therapy is a necessary element ..."
 
1 - 100 of 1157 Items 1 2 3 4 5 6 7 8 9 10 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)